The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
in this study they showed that it was in older individuals uh basically your mean amplitude of glycemic excursions was your best predictor of your current cognitive function as measured on a mini mental state exam and then two years later after taking these dpb4 inhibitor drugs um the more your glycemic excursions improved so this the spikes got smaller the more your cognitive function improved
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.